You are here

relebactam

The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings

Yahoo/Benzinga

Sun, 07/14/19 - 04:09 pm

Seattle Genetics

Intuitive Surgical

Mirum Pharmaceuticals

Fulcrum Therapeutics

FDA Action Alert: Karyopharm, Merck and Celgene

BioSpace

Mon, 07/1/19 - 10:54 pm

Merck’s Relebactam Met Primary Endpoints in Phase 3 Study

Market Realist

Mon, 04/23/18 - 09:18 am

beta-lactamase inhibitors

clinical trials